Rate Control and Sinus Rhythm Maintenance in Atrial Fibrillation
Open Access
- 26 October 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (19) , 2144-2148
- https://doi.org/10.1001/archinte.158.19.2144
Abstract
ATRIAL FIBRILLATION is the most common significant cardiac arrhythmia, occurring in 1% of the US population.1 The prevalence of atrial fibrillation increases strikingly with older age; 4% of the population older than 60 years and 10% older than 80 years have atrial fibrillation. With the aging of the US population, atrial fibrillation is increasing in prevalence.2-4This publication has 11 references indexed in Scilit:
- Reversible high rate atrial fibrillation dilated cardiomyopathy.Heart, 1997
- National Patterns of Warfarin Use in Atrial FibrillationArchives of internal medicine (1960), 1996
- Paroxysmal atrial fibrillation. A common but neglected entityArchives of internal medicine (1960), 1996
- Newer developments in the management of atrial fibrillationAmerican Heart Journal, 1995
- Regional Variation across the United States in the Management of Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJournal of the American College of Cardiology, 1992
- Digoxin for Atrial Fibrillation: A Drug Whose Time Has Gone?Annals of Internal Medicine, 1991
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- The Cardiac Arrhythmia Suppression Trial (CAST)New England Journal of Medicine, 1989